Lannett Files ANDA For US Advair Rival
Firm Reveals It Is Also In Negotiations Over Additional Respiratory Opportunities
Lannett has become the latest company to file an ANDA for a generic rival to GSK’s Advair Diskus in the US. Meanwhile, the company has revealed that it is also exploring further respiratory opportunities.
